7th Postgraduate
Course for Training in
Reproductive Medicine and Reproductive Biology
Geneva WHO Collaborating Center in Human Reproduction
in collaboration with
UNDP/UNFPA/WHO/World Bank
Special Programme of Research, Development & Research Training in Human
Reproduction
Individual or all lectures listed here are public and can be attended by
anyone interested in the field
All lectures will be held in the Amphithéâtre de la Maternité
LECTURE PLAN
| 1.9 | 09.00h | Get together, formalities | |
| 10.00h | M. Brunschwig-Graf (Geneva) G. Benagiano (Geneva) A. Campana (Geneva) J.D. Vassalli (Geneva) J. Villar (WHO) |
Introduction | |
| 10.30h | E. Diczfalusy (Rönninge) | In search of human dignity; reproductive health and gender equity | |
| 14.30h | Presentation of the course and discussion | ||
| 2.9 | 09.00h | S. Schorderet (Geneva) | Gametogenesis |
| 10.00h | S. Schorderet (Geneva) | Gamete activation | |
| 11.00h | S. Schorderet (Geneva) | Gamete interaction during fertilization | |
| 14.30h | Visit of the CMU library | ||
| 3.9 | 09.00h | J.-D. Vassalli (Geneva) | Embryo development |
| 10.00h | J.-D. Vassalli (Geneva) | Experimental embryology | |
| 11.00h | A. Mauron (Geneva) | Ethical aspects of gene therapy | |
| 14.00h | J.-D. Vassalli, A. Mauron | Panel on ethical aspects of gene therapy | |
| 4.9 | 09.00h | P. Bischof (Geneva) | Embryo implantation in human |
| 10.00h | F. Urner (Geneva) | The IVF laboratory | |
| 11.00h | A. Wohlwend (Geneva) | The functional properties of trophoblastic cells | |
| 14.00h | Visit of the WHO library | ||
| 5.9 | 09.00h | A. de Agostini (Geneva) | Planning and preparing a paper |
| 10.00h | B. Mermillod (Geneva) | Guidelines for writing papers: statistical aspects | |
| 11.00h | J. Khanna (WHO) | WHO editorial style | |
| 8.9 | 09.00h | R. Gaillard (Lausanne) | The hypothalamus-hypophysis-gonadal axis |
| 10.00h | M.L. Aubert (Geneva) | Regulation of GnRH secretion | |
| 11.00h | M.L. Aubert (Geneva) | Use of GnRH agonists and antagonists | |
| 14.00h | S. Nazeer (WHO), E. Mégevand (Geneva), P. Vassilakos (Geneva) | Cervical cancer prevention activities between WHO’s Division of Reproductive Health and HUG | |
| 9.9 | 09.00h | P. Bischof (Geneva) | The menstrual cycle |
| 10.00h | P. Bischof (Geneva) | Hormone receptors | |
| 11.00h | E. Tribolet (Geneva) | Oxytocin in reproductive biology | |
| 10.9 | 09.00h | M. Morris (Geneva) | Principles of DNA diagnosis of genetic disorders |
| 10.00h | M. Morris (Geneva) | Prenatal DNA diagnosis: Practical examples | |
| 11.00h | S.E. Antonarakis (Geneva) | The human genome project and its impact in clinical medicine | |
| 11.9 | 09.00h | P. Sizonenko (Geneva) | Sexual differentiation |
| 10.00h | P. Sizonenko (Geneva) | Puberty : Physiology | |
| 11.00h | P. Sizonenko (Geneva) | Puberty : Pathology | |
| 14.00h | A. Campana (Geneva) | Internet and Medline | |
| 12.9 | 09.00h | M. Lalioti (Geneva) | Genes implicated in sex-differentiation |
| 10.00h | C. Blanchet (Geneva) | Genetic counseling | |
| 11.00h | S. Dahoun (Geneva) | Chromosomal pathology | |
| 14.00h | J. Kasonde (WHO) | Research capability strengthening in WHO/HRP | |
| 15.9 | 09.00h | O. Meirik (WHO) | Case-control and cohort studies |
| 10.00h | J. Villar (WHO) | Randomized controlled clinical trials | |
| 11.00h | J. Villar (WHO) | Protocol design | |
| 14.00h | J. Villar (WHO) | Reproductive health in Latin America and the Caribbean | |
| 16.9 | 09.00h | A. Morabia (Geneva) | Clinical epidemiology in reproductive medicine |
| 10.00h | O. Frank (WHO) | Vital statistics | |
| 11.00h | O. Frank (WHO) | Fertility and infertility demographic studies | |
| 14.00h | M. Boulvain (Geneva) | Evaluation of interventions in developing countries | |
| 17.9 | 09.00h | T. Farley (WHO) | Basic summary tables |
| 10.00h | T. Farley (WHO) | Assessing differences between groups | |
| 11.00h | T. Farley (WHO) | Estimation of sample size | |
| 14.00h | E.O. Akande (WHO) | Reproductive health in Africa and Eastern Mediterranean | |
| 18.9 | 09.00h | I.H. Shah (WHO) | Contraceptive use in different regions of the world |
| 10.00h | I.H. Shah (WHO) | Contraceptive choice | |
| 11.00h | F. Lüdicke (Geneva) | Medical eligibility criteria for initiating and continuing use of contraceptive methods | |
| 19.9 | 09.00h | G. Benagiano (Geneva) | Oral contraceptives |
| 10.00h | G. Benagiano (Geneva) | Risks and benefits of hormonal contraceptives | |
| 11.00h | G. Benagiano (Geneva) | Metabolic effects of hormonal contraceptives | |
| 14.00h | A. Mbakop (Cameroon) | Present situation of uterus cancers in Cameroon | |
| 22.9 | 09.00h | M. Rice (WHO) | Reproductive health promotion and education initiatives for adolescents |
| 10.00h | D. Griffin (WHO) | Immunocontraception | |
| 14.00h | D. Walker (Geneva) | Journal Club | |
| 23.9 | 09.00h | H. Von Hertzen (WHO) | Emergency contraception |
| 10.00h | H. Von Hertzen (WHO) | Induced abortion | |
| 11.00h | G. de Boccard (Geneva) | Male sterilization | |
| 24.9 | 09.00h | C. d’Arcangues (WHO) | Natural methods |
| 10.00h | G. Waites (WHO) | Male contraception | |
| 11.00h | P. Rowe (WHO) | IUD’s and barrier contraceptive methods | |
| 14.00h | H. Van Kets (Gent) | Clinical experience of LNG IUD | |
| 25.9 | 09.00h | C. d’Arcangues (WHO) | Long-acting hormonal methods for women |
| 10.00h | Yi Fei Wang (WHO) | Reproductive health in Asia and the Pacific | |
| 11.00h | J. Cottingham (WHO) | Gender perspectives and reproductive health | |
| 26.9 | 09.00h | A. Campana (Geneva) | Definition, prevalence and etiology of infertility |
| 10.00h | A. Campana (Geneva) | Evaluation of the infertile couple | |
| 11.00h | A. Campana (Geneva) | Recurrent abortion | |
| 29.9 | 09.00h | P. Graber (Geneva) | Pathology of male urogenital tract |
| 10.00h | A. de Agostini (Geneva) | Semen analysis | |
| 11.00h | A. de Agostini (Geneva) | Post-coital test | |
| 14.00h | H. Bathija (WHO) | Female sterilization | |
| 15.00h | H. Bathija (WHO) | Control of fertility in adolescence and premenopause | |
| 30.9 | 09.00h | R. Martin-du-Pan (Geneva) | Diagnosis and treatment of secretory causes of male infertility |
| 10.00h | G. de Boccard (Geneva) | Diagnosis and treatment of excretory causes of male infertility | |
| 11.00h | B. Ruedi (Neuchâtel) | Diagnosis and management of impotence | |
| 14.00h | D. Sakkas (Geneva) | Journal Club | |
| 1.10 | 09.00h | P.G. Bianchi (Geneva) | Diagnosis of ovulatory causes of infertility |
| 10.00h | D. Chardonnens (Geneva) | Hormonal treatment of female infertility | |
| 11.00h | D. Chardonnens (Geneva) | Monitoring of ovarian stimulation | |
| 2.10 | 09.00h | E. Johannisson (Geneva) | Dating of human endometrium |
| 10.00h | A. Stalberg (Geneva) | Medically assisted conception | |
| 11.00h | D. Sakkas (Geneva) | Embryo development in vitro | |
| 3.10 | 09.00h | M. Vallotton (Geneva) | Adrenal glands and reproduction |
| 10.00h | M. Goumaz (Geneva) | The thyroid gland and reproduction | |
| 11.00h | J. Philippe (Geneva) | Diabetes and reproduction | |
| 6.10 | 09.00h | G. de Candolle (Geneva) | Hysteroscopy |
| 10.00h | D. Stucki (Fribourg) | Diagnostic laparoscopy | |
| 11.00h | J. Salvat (France) | Operative laparoscopy | |
| 14.00h | G. de Candolle, J. Salvat and D. Stucki | Training in gynecologic endoscopy | |
| 7.10 | 09.00h | J. Villar (WHO) | Antenatal care |
| 10.00h | M. Boulvain (Geneva) | Maternal morbidity | |
| 11.00h | O. Irion (Geneva) | Evidence-based medicine in obstetrics | |
| 14.00h | ORAL PRESENTATIONS | ||
| 8.10 | 09.00h | Ph. Extermann (Geneva) | Fetal medicine |
| 10.00h | F. Béguin (Geneva) | Labor and delivery | |
| 11.00h | P. Hohlfeld (Lausanne) | Operative obstetrics | |
| 17.30h-20.30h | ORAL PRESENTATIONS | ||
| 9.10 | 09.00h | R. Guidotti (WHO) | Maternal care |
| 10.00h | J. Liljestrand (WHO) | Maternal mortality | |
| 11.00h | J. Liljestrand (WHO) | Midwifery | |
| 10.10 | 09.00h | D. Walker (Geneva) | The menopause |
| 10.00h | D. Walker (Geneva) | Hormone replacement therapy | |
| 11.00h | J.-Ph. Bonjour (Geneva) | Osteoporosis | |
NOTE
Lectures will end on October 10, 1997.
A written examination consisting in a multiple choice test will be held
on October 15, 1997.
During the course the students will be asked to prepare a short essay on
a subject proposed by the teachers of the course and to present the results
of this bibliographic research during a morning in October (10 minutes presentation).
The essay will contribute with the multiple choice test to the final evaluation
of the students.
Guidelines for the preparation of the literature reviews
Students will be asked to produce a written essay on one topic of personal
interest chosen among those proposed. For initial assistance the student
can contact the person responsible for the topic (see annex).
The written test will be a maximum of 10 pages long including a list of
25 to 30 relevant references. The deadline for written essay will be Monday,
September 29. The essay should be handwritten or typewritten in English.
The students will also be asked to give a 10 min. oral presentation on the
contents of their reviews. The presentations will take place on October
7th in the afternoon and on October 8th in the evening. The presentations
will be informal and provide a good occasion for discussion among the students
and examiners. The written essay will contribute to the final evaluation
together with the multiple choice test.
Edited by Aldo Campana,